The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation
Aesthetic Plastic Surgery · 2025
DOI: 10.1007/s00266-025-05434-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Suk Bae Seo und 8 weiteren Autor:innen. Beteiligte Einrichtung: SeoAhSong Dermatologic Clinic, Seoul, Korea. Hauptthemen laut MEDLINE: Rejuvenation, Polyesters, Skin Aging, Cosmetic Techniques. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Poly(D,L-lactic acid) (PDLLA) is increasingly used for skin rejuvenation, utilizing innovative delivery systems like needle-free injectors to enhance patient comfort and efficacy. OBJECTIVE: To evaluate the clinical efficacy and safety of PDLLA delivered through a microjet injector and to assess the durability of its rejuvenating effect over 24 weeks. METHODS: This study involved 40 patients who underwent five treatment sessions of PDLLA (Juvelook) treatment via a needle-free microjet system. Efficacy was assessed through clinical evaluation (GAIS), patient satisfaction surveys, and 3D imaging analysis at baseline, 8 weeks, and 24 weeks. RESULTS: GAIS scores improved from 1.48 ± 0.32 at baseline to 1.90 ± 0.28 at 8 weeks and 2.16 ± 0.26 at 24 weeks (p < 0.001). Patient satisfaction increased from 3.38 ± 1.12 to 7.95 ± 0.86 (8 weeks) and 8.71 ± 0.69 (24 weeks). 3D imaging showed progressive vector displacement, with a mean displacement of 1.5 ± 0.4 mm at 8 weeks and 2.3 ± 0.5 mm at 24 weeks, indicating sustained lifting and textural improvement. These effects are attributed to the high-velocity microjet delivery mechanism, which enables uniform intradermal dispersion with minimal trauma. CONCLUSION: PDLLA (Juvelook) delivered via needle-free injection (CUREJET, BAZ BIOMEDIC CO., LTD.) is a safe and effective modality for facial rejuvenation, offering a promising alternative to conventional methods. Further research is needed to explore long-term outcomes and mechanistic insights. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SeoAhSong Dermatologic Clinic, Seoul, Korea.
- Medical Research Inc., Seoul, Korea.
- Brandnew Aesthetic Surgery Clinic, Seoul, Korea.
- The Artisan Clinic Private Limited, Singapore, Singapore.
- EverKeen Medical Centre, Kowloon, Hong Kong.
- MH Plastic Surgery Clinic, Singapore, Singapore.
ORCID-Profile: Kyu-Ho Yi
Zitieren
APA
Seo, S. B., Wan, J., Yoon, S. E., Wong, I. K. J., Lee, K. W. A., Chua, D., Kim, J. H., Lee, W., & Yi, K. H. (2025). The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05434-2
Vancouver
Seo SB, Wan J, Yoon SE, Wong IKJ, Lee KWA, Chua D, et al. The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-05434-2
BibTeX
@article{Seo2025,
author = {Seo, Suk Bae and Wan, Jovian and Yoon, Song Eun and Wong, Isaac Kai Jie and Lee, Kar Wai Alvin and Chua, Deborah and Kim, Jin-Hyun and Lee, Won and Yi, Kyu-Ho},
title = {The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation},
journal = {Aesthetic Plastic Surgery},
year = {2025},
doi = {10.1007/s00266-025-05434-2}
}
EUVIMED